Targeted News Service

FDA Center for Drug Evaluation & Research Issues Warning Letter to CareFusion 213
May 06, 2026

WASHINGTON, May 6 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to CareFusion 213 LLC from its Center for Drug Evaluation and Research:

* * *

Recipient: Mr. Thomas E. Polen, Jr., Chairman, CEO and President, CareFusion 213, LLC, 1 Becton Drive, Franklin Lakes, NJ 07417-1880, United States

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

Warning L . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form